Use of (3r)-4--3-(4-chlorophenyl) butanoic acid for treating urinary incontinence
AssigneeXenoPort, Inc.
InventorsAetna W. Wun, David J. Wustrow
Life of this patent
Estimating the term…
Abstract
Use of (3R)-4-{[(1S)-2-methyl-1-(2-methylpropanoyloxy)propoxy]carbonylamino}-3-(4-chlorophenyl) butanoic acid for treating urinary incontinence is disclosed.
Claims20
A method of treating urinary incontinence in a patient comprising administering to a patient in need of such treatment a therapeutically effective amount of (3R)-4-{[(1S)-2-methyl-1-(2-methylpropanoyloxy)propoxy]carbonylamino}-3-(4-chlorophenyl) butanoic acid or a pharmaceutically acceptable salt thereof.
A method of treating urinary incontinence in a patient comprising administering to a patient in need of such treatment a therapeutically effective amount of a pharmaceutical composition comprising (3R)-4-{[(1S)-2-methyl-1-(2-methylpropanoyloxy)propoxy]carbonylamino}-3-(4-chlorophenyl) butanoic acid, or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable vehicle.
Dependencies are inferred from the claim text.